B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus

被引:55
|
作者
Yu, Fuqu
Feng, Jiaying
Harada, Josephine N.
Chanda, Sumit K.
Kenney, Shannon C.
Sun, Ren
机构
[1] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[2] Zhejiang Univ, Dept Bioengn, Hangzhou, Peoples R China
[3] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA
[4] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53706 USA
关键词
KSHV; reactivation; XBP-1;
D O I
10.1016/j.febslet.2007.06.056
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The herpesvirus life cycle has two distinct phases: latency and lytic replication. The viral immediate early protein replication and transcription activator (RTA) plays a central role in mediating the balance between these two phases. Here, we demonstrate that a B cell terminal differentiation factor X-box binding protein 1 (XBP-1) can effectively initiates Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation by activating the RTA promoter, which results in the induction of other viral lytic transcripts. We also showed splicing of the XBP-1 mRNA which specifically occurs during B cell differentiation is critical in triggering KSHV reactivation. This work demonstrates the integration of KSHV reactivation mechanisms with host cell differentiation. (c) 2007 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:3485 / 3488
页数:4
相关论文
共 50 条
  • [21] The Chromatin Landscape of Kaposi's Sarcoma-Associated Herpesvirus
    Toth, Zsolt
    Brulois, Kevin
    Jung, Jae U.
    VIRUSES-BASEL, 2013, 5 (05): : 1346 - 1373
  • [22] Lytic Reactivation of the Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Is Accompanied by Major Nucleolar Alterations
    Atari, Nofar
    Rajan, K. Shanmugha
    Chikne, Vaibhav
    Cohen-Chalamish, Smadar
    Doniger, Tirza
    Orbaum, Odelia
    Jacob, Avi
    Kalt, Inna
    Michaeli, Shulamit
    Sarid, Ronit
    VIRUSES-BASEL, 2022, 14 (08):
  • [23] Epidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus)
    Plancoulaine, S
    Abel, L
    Gessain, A
    PATHOLOGIE BIOLOGIE, 2002, 50 (08): : 496 - 502
  • [24] An easily transfectable cell line that produces an infectious reporter virus for routine and robust quantitation of Kaposi's sarcoma-associated herpesvirus reactivation
    DeCotiis, Jennifer L.
    Ortiz, Noelle C.
    Vega, Brian A.
    Lukac, David M.
    JOURNAL OF VIROLOGICAL METHODS, 2017, 247 : 99 - 106
  • [25] Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection
    Katano, Harutaka
    HUMAN HERPESVIRUSES, 2018, 1045 : 357 - 376
  • [26] Kaposi's sarcoma-associated herpesvirus: A sexually transmissible infection?
    Grulich, AE
    Olsen, SJ
    Luo, K
    Hendry, O
    Cunningham, P
    Cooper, DA
    Gao, SJ
    Chang, Y
    Moore, PS
    Kaldor, JM
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1999, 20 (04): : 387 - 393
  • [27] Inhibition of nuclear factor κB activity by viral interferon regulatory factor 3 of Kaposi's sarcoma-associated herpesvirus
    Taegun Seo
    Junsoo Park
    Chunghun Lim
    Joonho Choe
    Oncogene, 2004, 23 : 6146 - 6155
  • [28] Inhibition of nuclear factor κB activity by viral interferon regulatory factor 3 of Kaposi's sarcoma-associated herpesvirus
    Seo, T
    Park, J
    Lim, C
    Choe, J
    ONCOGENE, 2004, 23 (36) : 6146 - 6155
  • [29] Kaposi's sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters
    Izumiya, Yoshihiro
    Algalil, Adhraa
    Espera, Jonna M.
    Miura, Hiroki
    Izumiya, Chie
    Inagaki, Tomoki
    Kumar, Ashish
    JOURNAL OF VIROLOGY, 2024, 98 (02)
  • [30] Kaposi's Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi's Sarcoma
    Jary, Aude
    Veyri, Marianne
    Gothland, Adelie
    Leducq, Valentin
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    CANCERS, 2021, 13 (24)